Tracon completes private placement

On March 14, Tracon Pharmaceuticals Inc. (NASDAQ:TCON) raised $1 million through the sale of 222,222 shares at $4.50 on March 14 under a new, 30-month stock purchase agreement with Aspire Capital Fun...